Noa Davis
Overview
Explore the profile of Noa Davis including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
173
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kardash T, Rodin D, Kirby M, Davis N, Koman I, Gorelick J, et al.
Behav Brain Res
. 2019 Nov;
379:112361.
PMID: 31734264
The effects of cannabis reported by users range from experiences of euphoria and anxiolytic effects to paranoia, anxiety, and increased risk of depression. Attempts to reconcile the apparent contradictions in...
2.
Yang G, Hamadeh I, Katz J, Riva A, Lakatos P, Balla B, et al.
J Bone Miner Res
. 2017 Sep;
33(1):91-98.
PMID: 28856724
Osteonecrosis of the jaw (ONJ) is a rare, but serious drug side effect, mainly associated with the use of intravenous (iv) bisphosphonates (BPs). The purpose of this study was to...
3.
Davis N, Shtabsky A, Lew S, Rona R, Leibovitch I, Nativ O, et al.
Eur Urol Focus
. 2017 Jul;
4(3):388-394.
PMID: 28753799
Background: CellDetect is a unique histochemical stain enabling color and morphological discrimination between malignant and benign cells based on differences in metabolic signature. Objective: The objective of the present study...
4.
Davis N, Mor Y, Idelevich P, Terkieltaub D, Ziv V, Elkeles A, et al.
J Urol
. 2014 Jul;
192(6):1628-32.
PMID: 24992334
Purpose: CellDetect® is a unique platform technology comprising a proprietary plant extract and 3 dyes that enables color discrimination between malignant (red) and benign (green) cells based on specific metabolic...
5.
Shaham O, Gueta K, Mor E, Oren-Giladi P, Grinberg D, Xie Q, et al.
PLoS Genet
. 2013 Mar;
9(3):e1003357.
PMID: 23516376
During development, tissue-specific transcription factors regulate both protein-coding and non-coding genes to control differentiation. Recent studies have established a dual role for the transcription factor Pax6 as both an activator...
6.
Davis N, Mor E, Ashery-Padan R
Development
. 2010 Dec;
138(1):127-38.
PMID: 21138975
The embryonic ocular neuroepithilium generates a myriad of cell types, including the neuroretina, the pigmented epithelium, the ciliary and iris epithelia, and the iris smooth muscles. As in other regions...
7.
Kroeber M, Davis N, Holzmann S, Kritzenberger M, Shelah-Goraly M, Ofri R, et al.
Hum Mol Genet
. 2010 Jun;
19(17):3332-42.
PMID: 20538882
Heterozygous mutations in PAX6 are causative for aniridia, a condition that is frequently associated with juvenile glaucoma. Defects in morphogenesis of the iridocorneal angle, such as lack of trabecular meshwork...
8.
Davis N, Yoffe C, Raviv S, Antes R, Berger J, Holzmann S, et al.
Dev Biol
. 2009 Jul;
333(1):132-42.
PMID: 19563798
Pax6 is a highly conserved transcription factor that controls the morphogenesis of various organs. Changes in Pax6 dosage have been shown to affect the formation of multiple tissues. PAX6 haploinsufficiency...